William King

Authored Items
Few Actionable Genomic Alterations Identified in Renal-Cell Carcinoma
William King
TOP - September 2020 Vol 13, No 5 in Renal-Cell Carcinoma
Adjuvant Treatment with Osimertinib Is Highly Effective in EGFR-Mutated Earlier-Stage NSCLC
William King
TOP - September 2020 Vol 13, No 5 in Lung Cancer
Capmatinib Shows Promise in MET-Amplified Non–Small-Cell Lung Cancer
William King
TOP - September 2020 Vol 13, No 5 in Lung Cancer
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular Lymphoma and Marginal-Zone Lymphoma
William King
TOP - September 2020 Vol 13, No 5 in Lymphoma
Nivolumab plus Ipilimumab May Be a New First-Line Option for Patients with MSI-H or dMMR Metastatic Colorectal Cancer
William King
TOP - September 2020 Vol 13, No 5 in Colorectal Cancer
Adavosertib Monotherapy Demonstrates Promising Clinical Activity in Uterine Serous Cancer
William King
TOP - September 2020 Vol 13, No 5 in Emerging Therapies, Gynecologic Cancers
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
William King
TOP - September 2020 Vol 13, No 5 in Breast Cancer
Last modified: August 17, 2020